Vaccivox 51 Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.50 M
as on 19-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Vaccivox 51
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ulaganathan Saravanan and Saravanan Geetha serve as directors at the Company.
- CIN/LLPIN
U24110TN2020PTC137770
- Company No.
137770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaccivox 51?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ulaganathan Saravanan  | Director | 08-Sep-2020 | Current |
| Saravanan Geetha | Director | 08-Sep-2020 | Current |
Financial Performance of Vaccivox 51.
Enhance accessibility to Vaccivox 51's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vaccivox 51?
Unlock access to Vaccivox 51's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_417076.webp)
Nerds Hub (E) Private LimitedActive 6 years 19 daysUlaganathan Saravanan and Saravanan Geetha are mutual person
Exceljuta Talent Solution Private LimitedActive 9 years 2 monthsUlaganathan Saravanan and Saravanan Geetha are mutual person
Altascio Technologies India Private LimitedActive 3 years 5 monthsUlaganathan Saravanan is a mutual person
Vspark Enterprises LlpInactive For E-Filing 1 year 10 monthsUlaganathan Saravanan is a mutual person
- Axiom Infotech Private LimitedActive 22 years 1 month
Ulaganathan Saravanan and Saravanan Geetha are mutual person
- Alpha De Serve India Private LimitedActive 2 years 9 months
Ulaganathan Saravanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaccivox 51?
Vaccivox 51 has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaccivox 51, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaccivox 51's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
